• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Executive Moves: Daiichi Sankyo Co.

    Valitacell, Solentim Form Biologics Collaboration

    Werum, B-EN-G Enter Partnership

    Janssen, Morphic Ink Deal Worth up to $750M

    Catalent Appoints Tech Ops SVP
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Oakrum, Aucta Form Devt. & Mfg. Partnership

    Emergex Secures State-of-the-Art R&D Facility

    WuXi Biologics Completes EMA GMP Inspection

    Achillion Expands with Launch of PA Office

    ACG Capsules Expands in Brazil
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Implementing AI in Drug Discovery

    Valitacell, Solentim Form Biologics Collaboration

    Werum, B-EN-G Enter Partnership

    Janssen, Morphic Ink Deal Worth up to $750M

    Merck to Acquire Immune Design for $300M
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    WuXi Biologics Completes EMA GMP Inspection

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Vetter Pharma International GmbH

    Federal Equipment Company

    Emergent BioSolutions, Inc.

    Ajinomoto Bio-Pharma Services

    Ascendia Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Ascendia Pharmaceuticals

    Aphena Pharma Solutions, Inc.

    Reed-Lane, Inc.

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    DCAT Week ’19

    Where Business Gets Done

    Related CONTENT
    • Aerie Pharma, DSM Biomedical Expand Collaboration
    • Thermo Fisher Launches Ion AmpliSeq HD Technology
    • Thermo Fisher to Acquire BD’s Advanced Bioprocessing Biz
    • Marina Biotech Becomes Adhera Therapeutics
    • Getting to First-in-Human Clinical Trials
    01.25.19
    DCAT Week, the premier business development event for companies engaged in pharmaceutical development and manufacturing, will take place in March 2019 (March 18-21) with a slate of networking opportunities, education programs, and executive forums.

    DCAT Week is hosted and organized by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported global business development association supported by more than 500 member-companies composed of innovator- and generic-drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

    Business gets done at DCAT Week because the right people are there—92% of attendees are high-level decision makers, with one in four attendees being C-Suite executives.

    The focus of this popular event is to provide a forum for high-level strategic meetings with key decision makers, timely education programs, and important networking opportunities. Reserved private business meeting spaces in eight Official DCAT Week Hotels offer the perfect venue for DCAT member companies to meet with their customers, suppliers and potential business partners. Throughout the week, industry education programs, executive forums, and networking events provide additional opportunities for attendees to stay informed and build their business network.

    Monday: Business Intelligence & Monday Night Meet-Up
    DCAT Week kicks off with the DCAT Member Company Announcement Forum. This fast-paced forum, attended by the industry press, is an exclusive venue for senior executives at DCAT member companies to present short, targeted announcements on major news from their companies impacting the pharmaceutical manufacturing value chain, including mergers and acquisitions (including post-M&A integration) and significant manufacturing expansions.

    The focus on business intelligence continues in the afternoon with the Pharma Industry Outlook Program & Networking Reception that will begin with a pharmaceutical market overview by IQVIA followed a panel discussion of leading industry experts on the key market and policy issues in drug pricing and the industry impact, including on bio/pharmaceutical manufacturers and suppliers.

    A new networking event, the Monday Night Meet-Up: Networking with a Dash of Trivia, gives attendees the opportunity to connect with colleagues and friends and test their knowledge during a casual trivia competition, while supporting STEM education. Proceeds from the event support DCAT’s scholarship initiatives, including DCAT’s participating as a Special Awards Organization for the Intel International Science and Engineering Fair.

    Tuesday: Nobel Laureate Dr. Francis H. Arnold, Executive Insights, a Fun Run, & More
    Tuesday will start off bright and early with the inaugural DCAT Week Central Park Run. Participants will be bussed to and from the park and enjoy a workout exploring NYC’s beloved park. In case of rain, the run will be rescheduled for Thursday morning.

    Tuesday will also feature two Executive Insights Forums. Marc Casper, President and CEO of Thermo Fisher Scientific, in Executive Insights I: A CEO View: Drug Development, Manufacturing, and New Technologies, will provide an inside view from the C-Suite on the key issues shaping the current and future direction of the pharmaceutical industry, including drug development. He will also provide insights on how partnerships in external development and manufacturing are evolving and what the future may hold.

    A second program, Executive Insights II: The Future of Pharma/Biopharm Manufacturing and Supply, will feature on-stage interviews with executives from Bristol-Myers Squibb and Spark Therapeutics on the major drivers influencing pharmaceutical manufacturing and supply, including how technology and product mix will impact the future of supply lines and how pharmaceutical companies and manufacturing partners are meeting these opportunities and challenges.

    A special DCAT Week Keynote Address will feature Dr. Frances H. Arnold, Nobel Laureate in Chemistry (2018). Dr. Arnold, the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry and the Director of the Donna and Benjamin M. Rosen Bioengineering Center at the California Institute of Technology, was awarded the Nobel Prize in Chemistry in 2018 for pioneering the use of directed evolution to engineer enzymes. She conducted the first directed evolution of enzymes, which are proteins that catalyze chemical reactions, and refined the methods that are now used to develop new biocatalysts, which are applied in pharmaceutical synthesis, the manufacture of other chemicals, and in the production of renewable fuels. She will share her journey of innovation, including the key milestones—both the opportunities and challenges—that she has encountered and how she addressed them to achieve success. Dr. Arnold is only the fifth woman to receive the Nobel Prize in Chemistry.

    To wrap up the day, the DCAT Member Company Networking Reception is one of the largest networking events of the week with over 700 members in attendance. After a busy day of meetings, it is the perfect opportunity to catch up with colleagues before heading head out to dinners. 

    Wednesday:  Women’s Networking Breakfast & Industry Education
    The day begins early with the DCAT Women’s Networking Breakfast that will feature a presentation by Ellyn Spragins, New York Times bestselling author, speaker and founder of What I Know Now® Enterprises that will include a short presentation, self-discovery exercise for the audience, and an on-stage Letters To My Younger Self® exercise with a pharmaceutical executive.

    The education program, Sourcing and Procurement: The Next Generation, will explore two topics. New Modalities: Considerations from a Fast-Paced Sourcing World will feature two senior executives from Celgene who will examine considerations in strategic sourcing for evaluating capabilities, mitigating risk, scaling and maturing a supplier ecosystem to support cell and gene therapies while managing traditional modalities. The second topic, New Tools Toward Robustness, Efficiencies and Risk Management in Sourcing, will look at one company’s approach in driving productivity and performance improvements through a multi-level approach that encompassed global strategic sourcing on selected categories, improved coordination in the sales and operations planning process to more efficiently manage active pharmaceutical ingredient global inventory, and innovation in talent management.

    DCAT will also hold a specialized program designed for emerging pharmaceutical/biopharmaceutical and their partners in drug development and manufacturing and supply. Emerging Pharma: Aligning Regulators, Investors and Suppliers to Assure Successful Drug Development will explore two topics. Managing Changing Regulatory Requirements from Pre-IND to NDA Approval is designed to help emerging pharma companies avoid a major pitfall in the development process by providing sufficient preclinical and chemistry, manufacturing and controls (CMC) data to support the start of Phase I testing while ensuring flexibility for continued process and formulation improvements throughout clinical development and commercialization.  The second topic, How Investors and Other Parties Impact Emerging Pharma Development Decisions, will feature a panel of pharmaceutical executives (Pfizer and Artara Therapeutics), a venture capitalist (Deerfield Management), and development consultant (BioProcess Technology Consultants) to provide insight on the expectations of investors, pharmaceutical company partners, and other stakeholders on the issues impacting drug development.

    Inside Canada: NAFTA 2.0: Trans-Border Trade and the Impact on Pharma Manufacturing and Supply, will provide industry insights on the key issues impacting pharmaceutical manufacturing, supply, and pharmaceutical trade inside and with Canada. Speakers will discuss the impact of the new trade pact, the United States–Mexico–Canada Agreement (i.e., NAFTA 2.0) on the US and Canada, including on intellectual property and the flow of pharmaceutical ingredients and pharmaceutical products. This program is provided by DCAT to deliver information of a regional focus through a special partnership with Pharmed Canada, a Montreal-based health industries manufacturing and R&D outsourcing network.

    Thursday: An elegant finale to DCAT Week
    A black-tie tradition since 1926, the DCAT Annual Dinner held in the Grand Ballroom at the New York Hilton is an elegant finale to an incredible week of meetings, education and business networking. The over 2,000 DCAT members and their guests will enjoy an evening with Dale Earnhardt, Jr., professional race car driver, champion team owner, businessman, and one of the sport’s most enduring personalities. CP

    Visit www.dcatweek.org for a complete schedule of programs and events.
    Related Searches
    • Development
    • sourcing
    • pharma companies
    • ceo
    Suggested For You
    Product Showcase Product Showcase
    BASi Names CEO BASi Names CEO
    Thermo Fisher Opens Shanghai Bioprocess Design Center Thermo Fisher Opens Shanghai Bioprocess Design Center
    Thermo Fisher Scientific Introduces Savant SpeedVac Systems Thermo Fisher Scientific Introduces Savant SpeedVac Systems
    Pharma Future: Trends to Watch Pharma Future: Trends to Watch
    Thermo Scientific Launches Orbitrap ID-X with Mass Spec Software Thermo Scientific Launches Orbitrap ID-X with Mass Spec Software
    DCAT Elects President DCAT Elects President
    Thermo Fisher Officially Opens New Facility Thermo Fisher Officially Opens New Facility
    Thermo Fisher, Symphogen Enter Collaboration Thermo Fisher, Symphogen Enter Collaboration
    Aerie Pharmaceuticals Launches GMP Facility Aerie Pharmaceuticals Launches GMP Facility
    Getting to First-in-Human Clinical Trials Getting to First-in-Human Clinical Trials
    Marina Biotech Becomes Adhera Therapeutics Marina Biotech Becomes Adhera Therapeutics
    Thermo Fisher to Acquire BD’s Advanced Bioprocessing Biz Thermo Fisher to Acquire BD’s Advanced Bioprocessing Biz
    Thermo Fisher Launches Ion AmpliSeq HD Technology Thermo Fisher Launches Ion AmpliSeq HD Technology
    Aerie Pharma, DSM Biomedical Expand Collaboration Aerie Pharma, DSM Biomedical Expand Collaboration

    Related Features

    • Cold Chain Management
      Temperature-Controlled Logistics

      Temperature-Controlled Logistics

      Cryoport tackles market needs with new NJ facility
      Betsy Louda, Contract Pharma 01.25.19

    • Solid Dosage/Creams/Ointments
      Reducing Pill Burden

      Reducing Pill Burden

      Challenges and solutions for lowering the pill burden of amorphous spray dried dispersion drug products
      Deanna Mudie, Aaron Stewart, Stephanie Buchanan, Alyssa Ekdahl, Lonza Pharma & Biotech 01.25.19

    • Drug Delivery
      Nasal Drug Delivery

      Nasal Drug Delivery

      A look at best practices for testing nasal drug delivery devices
      Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC 01.25.19


    • AI in Pharma: Transforming Data into Drugs

      AI in Pharma: Transforming Data into Drugs

      Jane Z. Reed of Linguamatics discusses the potential benefits and obstacles leveraging data through AI
      Kristin Brooks, Contract Pharma 01.25.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19

    • Regulatory Affairs | Serialization
      Serialization Compliance: Understanding the Challenges

      Serialization Compliance: Understanding the Challenges

      Pharmaceutical Industry Trails Behind on Serialization for DSCSA.
      Peter F. Sturtevant, Senior Director, Industry Engagement – Pharmaceuticals, GS1 US 01.25.19


    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19

    • Facilities | Lyophilization
      Rising Demand for Lyophilized Products

      Rising Demand for Lyophilized Products

      Jubilant installs new oven to increase manufacturing capacity and keep up with biopharma’s growing need for lyophilization services
      Tim Wright, Contract Pharma 01.25.19

    • Drug Development
      Future Trends in the CDMO Space

      Future Trends in the CDMO Space

      And how to navigate them for successful drug development
      Guillaume Plane, Global Development and Marketing Manager, BioReliance End-to-End Solutions, MilliporeSigma 01.25.19


    • APIs | Cytotoxics and High Potency Manufacturing | Drug Development
      CDMOs On The Rise

      CDMOs On The Rise

      Tracking growth and strategies in the CDMO business
      Michel Le Bars, Managing Partner, Kurmann Partners AGe 01.25.19

    • APIs | Excipients
      Pharmaceutical Fine Chemicals Trends

      Pharmaceutical Fine Chemicals Trends

      Moving toward a new order in the pharmaceutical fine chemical / CD&M industry?
      Dr. Enrico T. Polastro, Vice President, Arthur D. Little Benelux SA/NV 11.13.18

    • Laboratory Testing
      Necessary, Appropriate, Valid: A mantra for facility managers creating complete health strategies

      Necessary, Appropriate, Valid: A mantra for facility managers creating complete health strategies

      The challenge of maintaining colony health; the importance of health monitoring
      Emmanuel Gomas, European Services Manager, Envigo 11.13.18

    • Drug Development | Formulation Development
      Abuse Deterrent Formulations

      Abuse Deterrent Formulations

      A look at opioid abuse in North America and formulations to help avoid an epidemic.
      Damon Smith, Richard Dart and Christopher Hirst 11.13.18

    • Bioanalytical Services
      Viral Contaminant Testing in Biopharma Manufacturing

      Viral Contaminant Testing in Biopharma Manufacturing

      There is no single test to detect all potential viral contaminants in biopharmaceutical manufacturing.
      Richard Adair, Virology Manager, SGS Life Sciences, Glasgow, UK 11.13.18

    • Serialization
      Serialization Implementation

      Serialization Implementation

      Contract packagers talk serialization implementation trends.
      Tim Wright, Editor, Contract Pharma 11.13.18

    Breaking News
    • Valitacell, Solentim Form Biologics Collaboration
    • Executive Moves: Daiichi Sankyo Co.
    • Werum, B-EN-G Enter Partnership
    • Janssen, Morphic Ink Deal Worth up to $750M
    • Catalent Appoints Tech Ops SVP
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login